Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-12-14 Sale | 2023-01-05 3:41 pm | ESSA Pharma Inc. | EPIX | BERGER FRANKLIN M Director | 272,840 | $2.6721 | $729,052 | 684,404 (Direct) | View |
| 2022-11-21 Purchase | 2022-11-23 5:45 pm | Rain Therapeutics Inc. | RAIN | BERGER FRANKLIN M Director | 122,000 | $8.0966 | $987,790 | 1,005,207 (Direct) | View |
| 2022-11-11 Sale | 2022-11-15 8:00 pm | Atea Pharmaceuticals Inc. | AVIR | BERGER FRANKLIN M Director | 41,666 | $5.1525 | $214,685 | 778,353 (Direct) | View |
| 2022-11-08 Purchase | 2022-11-14 4:17 pm | Rain Therapeutics Inc. | RAIN | BERGER FRANKLIN M Director | 42,881 | $5.83 | $249,996 | 883,207 (Direct) | View |
| 2022-03-18 Purchase | 2022-03-22 5:45 pm | Kezar Life Sciences Inc. | KZR | BERGER FRANKLIN M Director | 80,000 | $16.25 | $1,299,800 | 890,691 (Direct) | View |
| 2021-09-21 Purchase | 2021-09-23 5:21 pm | Rain Therapeutics Inc. | RAIN | BERGER FRANKLIN M Director | 3,786 | $14.3 | $54,140 | 840,326 (Direct) | View |
| 2021-04-23 Purchase | 2021-04-27 5:05 pm | Rain Therapeutics Inc. | RAIN | BERGER FRANKLIN M Director | 125,000 | $16.95 | $2,118,900 | 836,540 (Direct) | View |
| 2021-02-22 Purchase | 2021-03-04 6:47 pm | ESSA Pharma Inc. | EPIX | BERGER FRANKLIN M Director | 57,000 | $27 | $1,539,000 | 957,244 (Direct) | View |
| 2020-11-03 Purchase | 2020-11-03 8:09 pm | Atea Pharmaceuticals Inc. | AVIR | BERGER FRANKLIN M Director | 41,666 | $24 | $999,984 | 820,019 (Direct) | View |
| 2020-06-11 Purchase | 2020-06-11 6:29 pm | Kezar Life Sciences Inc. | KZR | BERGER FRANKLIN M Director | 100,000 | $5.5 | $550,000 | 784,003 (Direct) | View |
| 2020-02-04 Purchase | 2020-02-05 8:15 pm | Kezar Life Sciences Inc. | KZR | BERGER FRANKLIN M Director | 120,846 | $2.6 | $314,200 | 684,003 (Direct) | View |
| 2019-12-02 Sale | 2019-12-04 6:28 pm | FIVE PRIME THERAPEUTICS INC. | FPRX | BERGER FRANKLIN M Director | 79,980 | $3.9679 | $317,353 | 5,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-06-29 Option Award | 2022-11-01 11:04 am | N/A 2032-06-29 | ESSA Pharma Inc. | EPIX | BERGER FRANKLIN M Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2022-06-01 Option Award | 2022-08-19 5:43 pm | N/A 2032-06-01 | Rain Therapeutics Inc. | RAIN | BERGER FRANKLIN M Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-21 7:48 pm | N/A 2032-06-16 | Atea Pharmaceuticals Inc. | AVIR | BERGER FRANKLIN M Director | 61,264 | $0 | 61,264 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-17 6:01 pm | N/A 2032-06-15 | Kezar Life Sciences Inc. | KZR | BERGER FRANKLIN M Director | 26,000 | $0 | 26,000 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-10 6:40 pm | N/A 2032-06-07 | Atreca Inc. | BCEL | BERGER FRANKLIN M Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2021-09-21 Exercise | 2021-09-23 4:26 pm | N/A N/A | Kezar Life Sciences Inc. | KZR | BERGER FRANKLIN M Director | 8,896 | $5.91 | 810,691 (Direct) | View |
| 2021-09-21 Exercise | 2021-09-23 4:26 pm | N/A N/A | Kezar Life Sciences Inc. | KZR | BERGER FRANKLIN M Director | 8,896 | $7.63 | 810,691 (Direct) | View |
| 2021-09-22 Exercise | 2021-09-23 4:26 pm | N/A N/A | Kezar Life Sciences Inc. | KZR | BERGER FRANKLIN M Director | 8,896 | $5.6 | 810,691 (Direct) | View |
| 2021-09-21 Exercise | 2021-09-23 4:26 pm | N/A 2028-04-16 | Kezar Life Sciences Inc. | KZR | BERGER FRANKLIN M Director | 26,688 | $0 | 810,691 (Direct) | View |
| 2021-06-28 Option Award | 2021-06-30 6:45 pm | N/A 2031-06-27 | Kezar Life Sciences Inc. | KZR | BERGER FRANKLIN M Director | 26,000 | $0 | 26,000 (Direct) | View |
| 2021-06-18 Option Award | 2021-06-21 5:34 pm | N/A 2031-06-17 | Atea Pharmaceuticals Inc. | AVIR | BERGER FRANKLIN M Director | 34,025 | $0 | 34,025 (Direct) | View |
| 2021-06-09 Option Award | 2021-06-11 4:34 pm | N/A 2031-06-08 | Atreca Inc. | BCEL | BERGER FRANKLIN M Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2021-05-14 Option Award | 2021-05-18 5:46 pm | N/A 2031-05-14 | Rain Therapeutics Inc. | RAIN | BERGER FRANKLIN M Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2021-04-27 Conversion | 2021-04-27 5:05 pm | N/A N/A | Rain Therapeutics Inc. | RAIN | BERGER FRANKLIN M Director | 1,479,935 | $0 | 836,540 (Direct) | View |
Ownership | 2021-04-22 7:18 pm | N/A N/A | Rain Therapeutics Inc. | RAIN | BERGER FRANKLIN M Director | 0 | $0 | 711,540 (Direct) | View |
| 2021-04-16 Disposition | 2021-04-19 7:42 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | BERGER FRANKLIN M Director | 5,000 | $38 | 0 (Direct) | View |
| 2021-04-16 Disposition | 2021-04-19 7:42 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | BERGER FRANKLIN M Director | 67,500 | $0 | 0 (Direct) | View |
| 2020-12-11 Option Award(A) | 2021-01-26 7:01 pm | N/A 2030-12-11 | ESSA Pharma Inc. | EPIX | BERGER FRANKLIN M Director | 16,500 | $0 | 16,500 (Direct) | View |
| 2020-12-03 Exercise | 2021-01-11 4:42 pm | N/A N/A | ESSA Pharma Inc. | EPIX | BERGER FRANKLIN M Director | 25,000 | $3.23 | 941,537 (Direct) | View |
| 2020-12-03 Exercise | 2021-01-11 4:42 pm | N/A N/A | ESSA Pharma Inc. | EPIX | BERGER FRANKLIN M Director | 2,184 | $3.81 | 941,537 (Direct) | View |
| 2020-12-03 Exercise | 2021-01-11 4:42 pm | N/A N/A | ESSA Pharma Inc. | EPIX | BERGER FRANKLIN M Director | 6,773 | $4.67 | 941,537 (Direct) | View |
| 2020-12-11 Option Award | 2021-01-11 4:42 pm | N/A 2030-12-11 | ESSA Pharma Inc. | EPIX | BERGER FRANKLIN M Director | 16,500 | $0 | 941,537 (Direct) | View |
| 2020-12-03 Exercise | 2021-01-11 4:42 pm | N/A N/A | ESSA Pharma Inc. | EPIX | BERGER FRANKLIN M Director | 8,250 | $4 | 941,537 (Direct) | View |
| 2020-12-03 Exercise | 2021-01-11 4:42 pm | 2022-03-21 2025-03-05 | ESSA Pharma Inc. | EPIX | BERGER FRANKLIN M Director | 42,207 | $0 | 941,537 (Direct) | View |
| 2020-11-03 Conversion | 2020-11-03 8:09 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | BERGER FRANKLIN M Director | 1,519,212 | $0 | 820,019 (Direct) | View |
| 2020-10-29 Option Award | 2020-10-30 5:47 pm | N/A 2030-10-28 | Atea Pharmaceuticals Inc. | AVIR | BERGER FRANKLIN M Director | 80,000 | $0 | 80,000 (Direct) | View |
Ownership | 2020-10-29 8:45 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | BERGER FRANKLIN M Director | 0 | $0 | 809,606 (Direct) | View |
Ownership | 2020-10-01 6:38 pm | N/A N/A | ESSA Pharma Inc. | EPIX | BERGER FRANKLIN M Director | 0 | $0 | 925,037 (Direct) | View |
| 2020-06-29 Option Award | 2020-07-01 5:50 pm | N/A 2030-06-29 | PROTEOSTASIS THERAPEUTICS INC. | PTI | BERGER FRANKLIN M Director | 17,400 | $0 | 17,400 (Direct) | View |
| 2020-06-24 Option Award | 2020-06-26 5:06 pm | N/A 2030-06-23 | Kezar Life Sciences Inc. | KZR | BERGER FRANKLIN M Director | 8,896 | $0 | 8,896 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-15 5:09 pm | N/A 2030-06-09 | Atreca Inc. | BCEL | BERGER FRANKLIN M Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2020-05-14 Option Award | 2020-05-15 5:43 pm | N/A 2030-05-13 | FIVE PRIME THERAPEUTICS INC. | FPRX | BERGER FRANKLIN M Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2019-10-04 Option Award | 2019-10-04 8:29 pm | N/A 2029-10-03 | Tocagen Inc | TOCA | BERGER FRANKLIN M Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2019-06-27 Option Award | 2019-07-01 4:15 pm | N/A 2029-06-27 | PROTEOSTASIS THERAPEUTICS INC. | PTI | BERGER FRANKLIN M Director | 15,300 | $0 | 15,300 (Direct) | View |
| 2019-06-25 Option Award | 2019-06-27 4:11 pm | N/A 2029-06-24 | Kezar Life Sciences Inc. | KZR | BERGER FRANKLIN M Director | 8,896 | $0 | 8,896 (Direct) | View |
| 2019-06-24 Conversion | 2019-06-24 4:45 pm | N/A N/A | Atreca Inc. | BCEL | BERGER FRANKLIN M Director | 150,630 | $0 | 97,808 (Direct) | View |
Ownership | 2019-06-19 5:12 pm | N/A N/A | Atreca Inc. | BCEL | BERGER FRANKLIN M Director | 0 | $0 | 131,974 (Direct) | View |
| 2019-06-10 Option Award | 2019-06-12 6:21 pm | N/A 2029-06-09 | FIVE PRIME THERAPEUTICS INC | FPRX | BERGER FRANKLIN M Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2019-05-29 Option Award | 2019-05-31 4:16 pm | N/A 2029-05-28 | Tocagen Inc | TOCA | BERGER FRANKLIN M Director | 20,000 | $0 | 20,000 (Direct) | View |